NCT00093275已完成2 期
A Phase II, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of HP184 Administered Orally Once Daily for Twenty-Four Weeks in Adult Subjects With Chronic Spinal Cord Injury (CSCI)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 262
- 试验地点
- 5
- 主要终点
- Change from baseline in total motor score of American Spinal Injury Association (ASIA) manual motor test at Week 24.
研究概览
简要总结
The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female subjects with incomplete (traumatic), chronic (defined as 18 months or more post spinal cord injury) SCI aged 18 to 65 years
- •CSCI must be categorized in classes C or D in the ASIA impairment scale. (C = Incomplete impairment with motor function preserved below the neurological level, and more than half of key muscles below the neurological level have a muscle grade less than
- •D = Incomplete impairment with motor function preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade more than or equal to 3).
- •The level of the SCI must be between C4 and T10 (neurological)
- •Subject has a measurable range of motion at the hips, knees and ankles and possesses potential propulsive activity (i.e. no functional contractures)
- •Female subjects of childbearing potential (those who are not surgically sterile or who are less than 2 years postmenopausal) must be using two forms of birth control, including a primary and a secondary form and have a negative pregnancy test immediately prior to treatment. Primary forms of contraception include: tubal ligation, partner's vasectomy, intrauterine devices, birth control pills, and topical/injectable/implantable/insertable hormonal birth control products. Secondary forms of contraception include diaphragms, latex condoms and cervical caps; each must be used with a spermicide.
排除标准
- •Any clinical evidence of recent fracture(s) within the last six months prior to study start.
- •Any history of Multiple Sclerosis or peripheral demyelinating disease or neuromuscular disorder.
- •Heart rate of less than 38 or greater than 100
- •Ashworth spasticity score of 0/4 or 4/4 at the hip or knee.
- •Subject whose medical condition requires mechanical ventilation.
- •Lower motor neuron injury, such as those with conus medullaris or cauda equina injuries.
- •Subject with lower extremity amputation or proximal femorectomy.
- •Subject with pressure ulcers stages 3 and
- •Subject medically or mentally unstable in judgment of Investigator.
- •Subject on tricyclic antidepressants such as nortriptyline, amitriptyline and imipramine.
- •Subject with ASIA motor score of greater than or equal to
- •Subject with ASIA sensory score of greater than or equal to
- •Subject with history of seizure within 2 years prior to study start.
- •Subjects who have participated in a clinical trial involving investigational medication within 30 days prior to administration of HP184 or placebo.
- •Female subjects with positive urine pregnancy test.
- •Female subjects who are breast feeding.
结局指标
主要结局
Change from baseline in total motor score of American Spinal Injury Association (ASIA) manual motor test at Week 24.
次要结局
- Safety evaluation.
研究者
研究点 (5)
Loading locations...
相似试验
招募中
2 期
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo NodularisPrurigo NodularisNCT06554509Guangdong Hengrui Pharmaceutical Co., Ltd423
已完成
2 期
Study of Daclizumab in Patients With Chronic, Persistent AsthmaAsthmaNCT00028288Facet Biotech120
终止
3 期
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisUlcerative ColitisNCT03259308Shire279
终止
3 期
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisUlcerative ColitisNCT03259334Shire380
已完成
2 期
A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaNCT04067518Institut de Recherches Internationales Servier28